1. Effect of ischemic time, fixation time, and fixative type on HER2/neu immunohistochemical and fluorescence in situ hybridization results in breast cancer
- Author
-
Gouri Nanjangud, Richard Pucci, Neda A. Moatamed, Alarice C. Lowe, Sophia K. Apple, Saeedeh Shapourifar-Tehrani, I. Peter Shintaku, David Y. Lu, and Nagesh Rao
- Subjects
Pathology ,medicine.medical_specialty ,Tissue Fixation ,Receptor, ErbB-2 ,Breast Neoplasms ,HER2/neu ,Fixatives ,Breast cancer ,Medicine ,Humans ,skin and connective tissue diseases ,Fixative ,Bouin solution ,In Situ Hybridization, Fluorescence ,Fixation (histology) ,biology ,medicine.diagnostic_test ,business.industry ,Carcinoma, Ductal, Breast ,General Medicine ,medicine.disease ,Immunohistochemistry ,biology.protein ,Female ,business ,Breast carcinoma ,Fluorescence in situ hybridization - Abstract
Accurate determination of HER2/neu status in breast carcinoma is essential. Alteration of preanalytic variables is known to affect HER2/neu results. American Society of Clinical Oncology (ASCO) and the College of American Pathologists (CAP) issued guidelines to standardize fixation for increased HER2/neu accuracy. We studied the effects of changing preanalytic variables on HER2/neu immunohistochemical and fluorescence in situ hybridization (FISH) results in a known HER2/neu+ invasive carcinoma. The clinical specimen was processed according to ASCO/CAP guidelines, with remaining tumor stored fresh without any fixatives for 4 days at 4°C and cut into core biopsy-sized pieces. Each was fixed in 10% formalin, 15% formalin, Pen-Fix (Richard-Allan Scientific, Kalamazoo, MI), Bouin solution, Sakura molecular fixative (Sakura Tissue-Tek Xpress, Torrance, CA), or zinc formalin for 0 to 168 hours. Immunohistochemical studies and FISH were performed. Compared with the clinical specimen, the samples showed no tumor degradation or marked difference by immunohistochemical studies, except the 1-hour 10% formalin and Bouin samples, or FISH, except the Bouin-fixed samples. Our study demonstrates that HER2/neu results remain accurate beyond ASCO/CAP-recommended preanalytic variables, with the exception of Bouin solution for FISH analysis.
- Published
- 2011